Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Clinical trial NCT02420860 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02420860
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hematopoietic Cell Transplantation Recipient Plasma Cell Myeloma

Start date: 2015-04-14
Primary completion: 2027-04-30
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.